Collaboration to leverage AbbVie’s therapeutic area expertise and Tentarix’s Tentacles™ platform, to develop novel multifunctional biologics against one target in oncology and another in immunology AbbVie will receive an exclusive option… Read More
WELL continues to focus on integrating and streamlining its operating businesses and is pleased to provide a number of related updates that supports its goal of improved profitable growth. All of… Read More
IPON to grant PharmAla an initial grant of $35,000, with a further total grant of $100,000 available in subsequent funding calls VANCOUVER, BC – PharmAla Biotech Holdings Inc. (“PharmAla” or… Read More
Fourth-Quarter revenues of $2.41 billion, up 10% on a Reported basis and up 4% on an Organic1 basis Full-Year revenues of $8.76 billion, up 8% on a Reported basis and 7%… Read More
SILVER SPRING, MD & RESEARCH TRIANGLE PARK, NC – United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced its financial results for the quarter and year ended December 31,… Read More
